Logo Lanfrica

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013–2016 West Africa Ebola outbreak in Guinea

Domain:

healthcare
Creator:
YapAitMatAbo
Publisher:
Elsevier BV
Host:

Licenses

https://www.elsevier.com/tdm/userlicense/1.0/https://www.elsevier.com/legal/tdmrep-licensehttp://creativecommons.org/licenses/by-nc-nd/4.0/

Similar

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

Background A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycopro

28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials

Abstract Background The recent Ebola virus

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo

Significance This paper describes findings from a seroepidemiologic study involv

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.

BACKGROUND: In March, 2016, a flare-up of Ebola virus disease was reported in Gu

Dying in honour: experiences of end-of-life palliative care during the 2013–2016 Ebola outbreak in Guinea

Abstract With no cure and a high mortality rate, Ebola virus disease (EVD) outbreaks require prepar

Technologies of trust in epidemic response: openness, reflexivity and accountability during the 2014–2016 Ebola outbreak in West Africa

Trust is an essential component of successful cooperative endeavours. The global health response to